Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Quest Diagnostics Inc. (DGX) shares rose 1.13% to $238.50, outperforming competitors like UnitedHealth and IQVIA during a broader market decline. This marks the stock's third consecutive day of gains, closing just short of its 52-week high. Trading volume remained below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Quest Diagnostics Inc. (DGX) rose 1.13% to $238.50 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.18% to 7,709.96 and Dow Jones Industrial Average falling 0.85% to 53,885.10.
This was the stock's third consecutive day of gains.
Quest Diagnostics Inc. closed 0.68% short of its 52-week high of $240.13, which the company achieved on July 28th.
The stock outperformed some of its competitors Thursday, as UnitedHealth Group Inc. (UNH) fell 2.13% to $403.97, IQVIA Holdings Inc. (IQV) fell 1.53% to $232.43, and Centene Corp. (CNC) fell 4.16% to $64.20.
Trading volume (634,117) remained 340,301 below its 50-day average volume of 974,418.
Data source: Dow Jones Market Data, FactSet. Data compiled August 6, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-06-26 1702ET